ASCIA News

  • National Allergy Strategy Updates
    The National Allergy Strategy is a partnership between ASCIA and Allergy & Anaphylaxis Australia. Several new and updated National Allergy Strategy resources have recently been launched, which are listed below.  NEW Allergy Aware Resource hub This resource hub contains the new...
  • Third COVID-19 vaccine dose recommended for people who are severely immunocompromised
    The Australian Technical Advisory Group on Immunisation (ATAGI) has released a statement, prepared in consultation with ASCIA, which recommends a third primary dose of COVID-19 vaccine for people who are severely immunocompromised. This includes people with primary...
  • New allergy guidelines for schools and children's education/care
    Best practice guidelines for prevention of severe allergic reactions (anaphylaxis) in schools and children's education/care (CEC) services were launched on Thursday 7 October 2021. The Guidelines were developed by the National Allergy Strategy (NAS), a partnership between...
  • COVID-19 vaccination digital certificates
    As stated in the ASCIA COVID-19 Vaccination FAQ 20, COVID-19 vaccines are recorded in an individual’s Immunisation History Statement in Australia, and on the National COVID-19 Immunisation Register (CIR) in New Zealand. Further information about digital certificates to...
  • Updated ASCIA eczema resources
    ASCIA has recently updated its online eczema (atopic dermatitis) resources to assist health professionals and patients/carers to treat and manage eczema. These resources now include information about treatment of severe eczema using immune modulating treatments. The...
  • Updated ASCIA anaphylaxis resources
    Over the past year ASCIA has updated and developed more than 24 online resources and 10 e-training courses to assist in the emergency treatment and management of anaphylaxis (severe allergic reactions). Each year ASCIA online anaphylaxis resources are viewed more than...
  • Updated ASCIA COVID-19 Information
    ASCIA Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Frequently Asked Questions (FAQ) for patients, consumers and carers has been updated In response to the arrival of the Moderna Spikevax vaccine in Australia and is available open access at...
  • ASCIA 2021 Virtual Conference Update
    Welcome to the ASCIA 2021 Virtual Conference which runs from Wednesday 1st to Friday 3rd September. We now have over 600 registered delegates, making this the largest ever ASCIA Conference and the major educational event for ASCIA members in 2021.  To view the Program Book go...
ASCIA Member Login

Site last updated: 22 Oct 2021
 

ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...

Join our mailing list here...

AIFA: Donate Now
AIFA: Donate Now
National Allergy Strategy
National Allergy Strategy
ASCIA: WAO Member
ASCIA: WAO Member
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.